Italy probes mystery death of Berlusconi sex trial witness

Remigio Civitarese
Marzo 17, 2019

Magistrates opened a murder investigation after the death this month of Iman Fadil, 34, who was due to give evidence at the former Italian prime minister's bribery trial.

Imane Fadil, 34, died March 1 at a Milan-area hospital, where she had been treated since January 29 for exhibiting "symptoms of poisoning", Milan prosecutor Francesco Greco said, according to the Italian news agency ANSA. ANSA quoted unnamed officials as saying the tests indicated a "mix of radioactive substances".

The model was also writing a book about her experiences at the parties with Berlusconi and magistrates investigating her death have obtained a copy of the manuscript, according to Italian newspapers. "It's always very sad when someone as young as this dies", he said. Berlusconi was initially found guilty and sentenced to seven years in prison, but the charges against him were dropped after an appeals court ruled that even if he did have sexual relations with the teenager, he did not know that she was under 18.

But he added: "I've never known this person and never spoke to her".

"What I read of her statements made me think that everything was invented, absurd", he said.

Imane Fadil
Italy Probes Death of Model Who Testified in Berlusconi Sex Trial- Reports

News reports said before Fadil slipped out of consciousness she told her lawyer and family that she feared she had been poisoned.

Milan chief prosecutor Francesco Greco told Reuters news agency there were "several anomalies" in Ms Fadil's medical records.

"The doctors have not identified with any certainty any pathology which can explain the death".

The former model first hit the headlines in 2012 when she gave detailed testimony about the goings-on at Berlusconi's parties at his villa in Arcore near Milan.

Berlusconi admitted that young women attended his soirees, but said the parties were nothing more than "burlesque contests".

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE